Investing.com -- Eikon Therapeutics Inc. (NASDAQ:EIKN) shares fell 5.7% following Wedbush analyst Robert Driscoll’s initiation of coverage with an Underperform rating and a $7.00 price target. The ...

Investing.com - JPMorgan initiated coverage on Eikon Therapeutics Inc. (NASDAQ:EIKN) with an Overweight rating and set a price target of $29.00, analyst Brian Cheng said Monday. The target represents ...

Investing.com - Mizuho initiated coverage on Eikon Therapeutics Inc. (NASDAQ:EIKN) with an outperform rating and set a price target of $26.00. The target represents nearly 90% upside from the current ...

Investing.com - BofA Securities initiated coverage on Eikon Therapeutics Inc. (NASDAQ:EIKN) with a Buy rating and a price target of $34.00. The stock currently trades at $13.78, near its 52-week low ...

Rolls-Royce is set to double its profit as it cashes in on booming defence spending as tensions continue to rise across the world. The engineering giant will report a £4.4 billion pre-tax profit in ...

All the Latest Game Footage and Images from Farewell, Eikon Sleeping on the job, running out of ice cream, and being locked out of his hometown due to a storm. Things just can’t seem to go right for ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

About United States Antimony Corp. United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following ...

Feb 19 : India's Reliance Industries and its unit Jio will invest 10 trillion rupees ($110 billion) over the next seven years in artificial intelligence, billionaire Chairman Mukesh Ambani said on ...